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ABSTRACT 
Aims: The etiology of esophageal squamous cell carcinoma (ESCC) in the high risk 
areas is largely unknown and a few environmental risk factors which have been 
identified do not explain its oddly high incidence in esophageal cancer belt. The aims 
of this thesis were to investigate the association of opium/tobacco consumption, 
serologic gastric atrophy, gastric mucosa-associated microbiota and contact with farm 
animals with the risk of ESCC. 
Methods: The population of Golestan Province in northeastern Iran has very high rates 
of ESCC. From 2003 to 2007, we administered a validated structured questionnaire to 
300 incident ESCC cases and 571 controls. Controls were matched to cases for 
neighborhood of residence, age (± 2 years), and sex. We measured serum pepsinogen I 
and II among 293 incident cases and 524 matched controls. Conditional logistic 
regression models were applied to calculate odds ratios (ORs) and 95% confidence 
intervals (CIs) adjusted for potential confounders. Furthermore we obtained a frozen 
gastric tissue biopsy from subjects with ESCC, esophageal squamous dysplasia, mid 
esophagus esophagitis, and age/sex-matched endoscopy clinic controls with healthy 
esophagus. To characterize bacterial lineage present in gastric mucosa, we performed a 
multiplex sequencing with GS-FLX Titanium targeting 16S rRNA. 
Results: Risk of ESCC was increased in those who used opium only (OR = 2.12, 95% 
CI: 1.21 - 3.74), and in those who used both tobacco and opium (2.35, 95% CI: 1.50 - 
3.67).   All forms of tobacco use (cigarettes, hookah, and nass) were associated with 
higher ESCC risk. 
Gastric atrophy (defined by a validated criterion, pepsinogen I <55 µg/dl) was 
associated with a two-fold increased risk (OR = 2.01, 95% CI: 1.18 - 3.45) of ESCC in 
the absence of non-atrophic pangastritis (defined as pepsinogen II < 11.8 µg/dl).  
Sequencing of 16S rRNA in gastric biopsy samples resulted 2075 operational 
taxonomic units (OTUs). Conditional logistic regression model based on principal 
coordinate analysis (PCoA) showed a marginal variation in pattern of gastric 
microbiota using Unifrac (p = 0.004) and weighted Unifrac distances (p = 0.018) 
between subjects with esophageal cancer or dysplasia and controls. No such difference 
between subjects with mid-esophagitis and controls was observed. 
Among four groups of farm animals (equines, ruminants, domestic canine and poultry) 
contact with ruminants was associated with an 8-fold increase in risk of ESCC. This 
association stayed stable when duration and level of contact were considered. 
Conclusions: Though opium and tobacco consumption are associated with the risk of 
ESCC in the study area, they do not explain the extreme high incidence in northern 
Iran. Changes in gastric environment might be linked to ESCC risk as fundal atrophy 
may increase the risk for ESCC and pattern of gastric microbiota differs in patients with 
esophageal squamous dysplasia (and ESCC) from subjects with normal esophagus. The 
observed relationship between lifelong contact with ruminants and ESCC needs further 
investigation. 
Key words: Esophageal cancer, opium, tobacco, atrophic gastritis, dental health, oral 
hygiene, pepsinogen, squamous dysplasia, microbiota, animal contact. 
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1 THESIS SUMMARY  
The incidence of esophageal cancer ranks 8
th
 worldwide (1). Its incidence varies 
between geographical areas with high rates in east Africa, South America, central and 
eastern Asia, and some parts of Europe. North eastern Iran and north central China are 
two ends of the “esophageal cancer belt” with peak incidence rates. Squamous cell 
carcinoma and adenocarcinoma are two main histology types of esophageal cancer. The 
predominant form of esophageal cancer observed in high risk area is squamous cell 
carcinoma. While smoking and alcohol drinking are two major known risk factors for 
esophageal squamous cell carcinoma (ESCC) in low risk areas, their contribution to the 
risk in the “esophageal cancer belt” is minor. The objective of this thesis is to 
investigate associations of some environmental factors with esophageal squamous cell 
carcinoma in the extreme-risk region of north eastern Iran.  
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2  BACKGROUND 
 
2.1 DESCRIPTIVE EPIDEMIOLOGY 
Based on estimated new cancer cases in 2008, incidence of esophageal cancer ranks 
6
th
 among men and its mortality ranks 5
th
 and 8
th
 among men and women worldwide 
(1). Wide variation in its incidence and distinct geographical hotspots are main 
epidemiologic features of esophageal cancer. Highest incidence rates have been 
reported from the “esophageal cancer belt”, an area that stretches from northern Iran to 
northern China (2) (Figure 1). 
The earliest report of the high incidence of esophageal cancer in northern Iran goes 
back to early 1970s which showed that in the eastern Caspian sea littoral (Gonbad area) 
incidence rates among men and women were 109/100 000 and 174/100 000 person-
years respectively (3, 4). Beside slightly higher female to male ratio in the high risk 
area of Northern Iran, the wide variation of incidence rates within relatively small 
geographic area is still evident as in regions a few hundred kilometers apart, its 
incidence dropped to 5/100 000. Albeit esophageal cancer incidence has dropped in this 
area, recently-developed cancer registry in the eastern Golestan province has confirmed 
that the rates are still high in eastern part of the province (5, 6).  
 
 
Figure 1. Map of esophageal cancer incidence rate (source: Globocan 2008, IARC) 
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2.2 RISK FACTORS STUDIED IN THIS THESIS 
In the high risk areas the prominent histologic type is squamous cell carcinoma 
(approximately 90%) (7). Esophageal squamous cell carcinoma (ESCC) is difficult to 
detect early, and almost always associated with poor outcome. So far no set of risk 
factors could fully explain its high incidence in northern Iran. 
 
2.2.1 Opium 
Studies conducted by the International Agency for Research on Cancer (IARC) and 
Institute of Public Health Research (IPHR) of Tehran University in the 1970s suggested 
that opium use may have a link to ESCC high incidence rate in Northern Iran(8).  
An ecologic study that compared people living in high-risk areas for ESCC with those 
living in lower risk areas found that 50% of the adult residents in the high-risk areas, 
compared to 11% of the residents in the reference group, tested positive for urine 
morphine metabolites. In another study among rural inhabitants, the prevalence of the 
urinary morphine metabolites with level of equal to or higher than 1 μg/ml was 6-fold 
higher among residents of high-risk compared to low-risk areas (9, 10).  
Opium consumption is still common among the old generation living in this region 
(11) and it is used a traditional medicine to treat pain, diarrhea, and insomnia. Whereby 
neither crude opium nor its refined products were proven to be mutagenic (12).  
However, inhaling the smokes from consumption of crude and refined opium might 
expose the individual to the potential carcinogens, including polycyclic aromatic 
hydrocarbons (PAHs). Histologic examination of non-tumorous esophageal tissues 
from ESCC cases and controls showed higher severity of anti-PAH antibodies staining 
in the same population (13). Considering that the link between this observation and 
exposure to opium was justified as an exposure secondary to cancer. Limited 
observations have shown that smoke condensates from opium and morphine cause 
mutations in Salmonella typhimurium (12, 14), and morphological transformations in 
cultured Syrian hamster embryo cells (15) whereas crude opium itself is not a mutagen 
(12, 14). Whereby at acute high doses, morphine-- as the major alkaloid in opium-- 
may alter the first pass hepatic clearance of the carcinogens i.e. N-nitrosodiethylamine 
(16, 17). The mechanisms responsible for the association which has been found 
between opium consumption and elevated ESCC risk need to be investigated.  
 
2.2.2 Tobacco and alcohol 
Heavy alcohol consumption and cigarette smoking are major causes of ESCC in most 
parts of the world (18-21). These two habits are correlated behaviorally. Based on 
questionnaire data, alcohol consumption was rare in Golestan Province during 1970s, 
especially among rural people, and therefore was unlikely to be an important cause of 
ESCC in this area(8), recent study confirmed the low  prevalence of alcohol 
consumption in this population (22). Cigarette smoking appeared to be associated with 
a 2-fold increased risk of ESCC which was not as strong as the observed 3-5 fold 
elevated risk in low risk area (19, 20). 
Tobacco consumption in the Golestan province is not restricted to cigarette. Habit of 
chewing nass which is a combination of tobacco, ash and lime was a relatively common 
habit among men living in the rural area (8). Smoking Hookah (water-pipe) is an 
additional but uncommon habit of using tobacco in this area (8, 9, 11). 
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Nass exposes users to both carcinogens in unburned tobacco (e.g., nitrosamines) and 
the carcinogens in ash (e.g., PAHs). Association between chewing tobacco and 
esophageal cancer has been shown through several studies(23). Smoking Hookah 
exposes users to the smoke from both tobacco and burning charcoal (24).  
Among other types of tobacco use, IARC considered chewing betel quid -which 
includes tobacco- as a risk factor for esophageal cancer (25). The association between 
hookah or chewing nass and ESCC has been minimally studied (26, 27). 
 
2.2.3 Gastric environment 
Impact of gastric environment on esophageal carcinogenesis has been addressed 
through observational studies (28, 29). As a link for this impact, gastric fundal atrophy 
has been shown to be associated with ESCC risk (30). Early studies have observed an 
overgrowth of bacteria in hypochlorhydric stomach through culturing bacteria in gastric 
juice (29). Recently sequencing-based methods showed lower bacterial diversity 
associated with higher gastric pH (31). 
 
2.2.3.1 Gastric mucosal atrophy 
Loss of appropriate glands in gastric mucosa is considered atrophy. Atrophic 
transformations might be in two forms: shrinkage or disappearance of mucosal glands 
and/or replacement of native glands by metaplastic ones (32). Long-standing 
Helicobacter pylori (H. pylori) infection and pernicious anemia are two medical 
conditions linked to gastric atrophy. In pernicious anemia, changes mainly affect 
gastric corpus while H. pylori infection results in multifocal atrophic gastritis. The 
association between gastric atrophy and a variety of malignancies was described in 
1870s through post-mortem examination (33). 
 Gold standard method for diagnosing atrophy is histologic evaluation of gastric 
biopsy specimens. In large epidemiologic studies, serologic biopsy of gastric function 
through measurement of biomarkers such as pepsinogens and gastrin has been utilized 
as a feasible diagnostic method (34). Pepsinogens are the inactive forms of pepsins; the 
proteinases in gastric juice responsible for digestion of protein. Two distinct 
immunologic types of pepsinogens are synthesized and stored in adult stomach mucosa; 
type I is mainly produced in the chief cells of corpus and type II synthesized in most 
part of gastric mucosa and also part of duodenum (35). Small proportion of pepsinogen 
enters the blood in correlation with the amount which is secreted into gastric 
lumen(36), its measurement has been long time applied as a marker for stomach 
secretary tissue mass (37). Pepsinogen I (PGI) decreases in parallel with progression of 
atrophy in corpus and pepsinogen II (PGII) changes or remains unchanged (35). 
Whereby decrease in PGI to PGII ratio (PGI/PGII) has been shown to be valuable in 
detecting fundic atrophy. The outcome of interest and the method of laboratory 
assessment vary among studies which aimed to evaluate diagnostic ability of 
pepsinogens. Implementing different cutoff values for defining fundic atrophy among 
different populations (38) have been mainly aimed at diagnostic ability of pepsinogens 
in gastric cancer screening.  PGI <70 µg/l and PGI/PGII ratio<3, measured by 
radioimmunoassay, it the most common-used the threshold to distinguish at risk 
population for gastric adenocarcinoma (39). 
H. pylori infection is considered as an early step in the process which includes fundic 
atrophy (40) while gastritis caused by H. pylori affects serum level of pepsinogen (41). 
   5 
It is likely that outcome of H. pylori-induced gastritis would differ among different 
populations. In the majority of infected individuals inflammation remains limited to the 
antrum (42) but in some infected individuals, inflammation extends from the antrum to 
the corpus and results in pangastritis (43) and it might be a step in the progression from 
gastritis toward fundic atrophy and gastric carcinogenesis (44). This might result in 
different proportion of pangastritis among infected population (45). 
Epidemiologic studies have shown an association between gastric atrophy and ESCC 
risk. An observed association between pernicious anemia and ESCC in a register based 
study was linked to gastric atrophy (46) plus a population-based case control study 
found that serologic marker of gastric atrophy was associated with an increased risk of 
ESCC (30). Association between gastric atrophy and ESCC has been studied in studies 
with different designs since then. However the magnitude of the reported measurement 
of risk varied (34, 47-50) among them, positive association, (34, 51, 52) no association 
(53) and an association with esophageal squamous dysplasia (54) have been reported. 
The underlying mechanism linking gastric atrophy to esophageal cancer has not been 
explained. Bacterial overgrowth in achlorhydric stomach was proposed as an 
explanation for this link (30). In an atrophic stomach, hypochlorhydria allows bacterial 
overgrowth (29) and may produce potential carcinogenic substances such as 
nitrosamines (55, 56), although no dose-response relation with severity of atrophy has 
been reported (48).  
Through gastric pH monitoring it was found that ESCC is often accompanied with a 
hypochlorhydric stomach even in conditions that atrophy could not be detected 
clinically (28, 57). Based on bacterial cultivation of gastric juice it is evident that an 
increase in gastric pH is followed by harboring a bacterial profile characterized by high 
production of nitrosamines (58, 59). 
 
2.2.3.2 Gastric mucosa-associated microbiota 
Human stomach was considered an inhospitable environment until the recognition of 
H. pylori (60). H. pylori is considered as a definite carcinogen (61) and associated with 
gastric adenocarcinoma (62). In some areas within the esophageal cancer belt, serologic 
studies showed majority of H. pylori strains contain cag pathogenicity island (63), 
however the same stomach might host both CagA positive and negative strains (64). 
Among H. pylori virulence factors, CagA antigen induces longer immune response 
(65). Association between H. pylori seropositiveness and ESCC has been evaluated in 
several case-control and cohort studies (30, 49, 63, 66-70) with little evidence of 
association. Results on CagA seropositivity and risk of esophageal cancer are 
controversial. 
 Gastric acidity is believed to be an important factor preventing other bacteria from 
colonizing in the stomach, although 16S rRNA sequencing of gastric mucosa revealed a 
diverse bacterial community colonizing human stomach (71). More than one hundred 
phylotypes have been detected in stomach mucosal biopsy of which 50% were derived 
from uncultivated bacteria (71). Although the role of H. pylori in the development of 
chronic inflammation of stomach is evident (72), little is known about other members 
of gastric microbiota community  (73).  H. pylori negative stomach showed high 
abundance of Streptococcus and Prevotella (74) among them certain Streptococcus 
species are resistant to low pH (75). In the presence of inflammation (antral gastritis) 
microbiota changes in favor of Firmicutes phylum and under-representation of 
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Proteobacteria phylum (74). Animal studies have shown that increase in abundance of 
certain members in Firmicutes phylum altered the pathogenicity of H. pylori (76). 
Furthermore long-term intragastric colonization of  H. pylori  decreases the abundance 
of Lactobacilli in Mongolian gerbils (77). Yet little is known about the role of gastric 
mucosa-associated microbiota in the progression of inflammation and production of 
carcinogens. 
 
2.2.4 Poor orodental hygiene 
Poor orodental hygiene, characterized by the number of tooth loss and low frequency 
of tooth brushing, has been associated with higher risk of esophageal cancer (78-82). 
The association between tooth loss and risk of esophageal cancer showed dose-
response relationship in most studies from the high risk areas. Some studies showed 
that number of decayed and filled teeth was associated with esophageal cancer risk 
after controlling for common risk factors including tobacco and alcohol consumption 
(80, 82). Furthermore this association appears to be valid even in esophageal squamous 
dysplasia as the only known ESCC precancerous status (83).  
 In general, tooth loss might be an indicator of a less healthy lifestyle. Having in mind 
that low socioeconomic status links with poor oral health, there are several suggested 
hypotheses: 
 (1) Poor oral hygiene may result in changes of the oral bacterial flora (84), causing 
periodontal diseases, and increased production of acetaldehyde and nitrosamines. A 
study showed that endogenous nitrosamine formation in oral cavities with poor hygiene 
is 8-fold higher than in those with good hygiene (85). The rich oral microbiota and 
frequent or chronic episodes of inflammation during several decades of life, maintain a 
low-grade chronic inflammation with inflammatory mediators which might reach 
esophageal mucosa through salivary flow (86). 
(3) Poor dentition could alter dietary habit due to reduction in masticatory ability (87). 
Edentulous people less likely consume fiber and vegetables (88).  
 
2.2.5 Animal contact 
Contact with animals has been suggested as a potential risk factor for ESCC in high 
risk areas based on the following ecologic data, veterinary workups and occupational 
cohort studies:  
(1) Geographical distribution of cancer belt is well-matched to the nomadic lifestyle 
with close contacts with equines, ruminants, canines and poultry among inhabitants of 
the eastern Caspian Sea littoral. This type of life style is disappearing as socioeconomic 
status has improved during the last decades. Shared environmental resources between 
farm animal and human might be an explanation for this association in ecologic 
observations. Another explanation could be exposure to farm animal products without 
industrial processing which is more common among villagers who keep animals within 
household. An early nutritional study showed higher consumption of sheep’s and goat’s 
milk in Northern Iran compared to the lower risk area (89).  
(2) Further suggestive observations stem from reports of high incidence of concurrent 
occurrence of  esophageal malignancies in endemic areas among autopsied chickens in 
Linxian, China (90) and cattle in Kenya (91). 
 (3) Studies on occupational exposure among butchers (92) and workers in poultry 
(93) or ruminant abattoirs’ plans (94) showed inconsistent results of increased risk of 
   7 
mortality due to esophageal cancer based on low number of cancer cases. A study on a 
cohort of workers in slaughtering plans of ruminants showed a standardized mortality 
ratio (95% CI) of 1.6 (1.0-2.4) based on 23 esophageal cancer cases (94). The same 
group reported an excess relative risk (95% CI) of esophageal cancer among poultry 
workers with 4.7 (1.1-22.5) based on 6 cases of esophageal cancer (93).  
Based on occupational studies, animal viruses were proposed as predisposing factors 
for cancer development. A group of farm animal viruses have already been defined to 
cause cancer of the alimentary tract (bovine papilloma viruses) (95) or upper 
aerodigestive tract (bovine nasal adenocarcinoma) (96). Although 58% of human 
pathogens are zoonotic (97), it is not clear whether these viruses are transmissible to 
human or within human population and whether they could cause cancer in human.  
 
2.2.6 Other risk factors 
Among environmental factors, possible risky habits include drinking or eating hot 
(hot tea) (98), Maté (99), and pickled vegetables (100). Recognized nutritional 
deficiencies consisted of low intake of fresh fruit and vegetables (19, 89), selenium and 
zinc deficiency (101, 102). High content of dietary haeme has been suggested as 
another dietary factor associated with a higher risk of ESCC (103). Known medical 
condition associated with ESCC risk are achalasia (104), pernicious anemia (46) and 
probably celiac disease (105). Among infectious agents, human papilloma virus (106) 
has been suggested as a risk factor however evidences are inconclusive yet (106-109). 
Poor socioeconomic status is consistently associated with a higher risk of esophageal 
cancer (110). 
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3 AIMS  
 To study the associations between opium and tobacco consumption and risk of 
ESCC. 
 
 To study the association between serologic gastric fundal atrophy and risk of 
ESCC. 
 
 To study the pattern of gastric mucosa-associated microbiota in subjects with 
ESCC, esophageal squamous dysplasia and mid-esophagitis compared with 
gastric microbiota in subjects with normal esophagus. 
 
 To study the association between farm animal contact and risk of ESCC. 
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4 SUBJECTS AND METHODS 
4.1 SUBJECTS (STUDIES I, II, IV) 
The study area included eastern part of Golestan province. Golestan province is 
located in eastern Caspian littoral. To ascertain incident cases, a specialized clinic 
(Atrak) for performing research and diagnosis of upper gastrointestinal tract cancers 
was established in the largest city of catchment area, Gonbad.  Atrak was the only 
specialized clinic for upper gastrointestinal cancer at the time of study. Efforts were 
made to inform public health system workers and physicians about the research and 
asked them to refer their new patients suspected of having upper gastrointestinal tract 
cancers to Atrak clinic.  
After a year of pilot study, from December 2003 to June 2007 cases were recruited. 
Including criteria were: giving consent to participate in the study,  presence of 
histopathologic evidence for   ESCC, being 18 years old and more, residing in the study 
area at the time of registration, and having no history of cancer. All the patients 
underwent upper gastrointestinal endoscopy. Biopsy samples were examined by 
experienced pathologists at Tehran University Digestive Disease Research Center 
(DDRC). 
For each case subject, we attempted to select two control subjects matched to the case 
for neighborhood of residence or village, age (± 2 years), and sex.  Though, for 
approximately 10% of cases, only one matched control could be found.  In both rural 
and urban areas, the annually- updated family health census was used to identify 
eligible controls. In each village, two controls were randomly selected from the list of 
eligible controls to interview. If potential control could not be interviewed, the next 
person on the list was invited, and so forth. In the cities, a list of the eligible controls 
was ordered by nearness of the addresses to the case’s residence, with the list starting 
from the person living closest to the case’s residence. 
 
4.2 SUBJECTS (STUDY III) 
For all subjects who were referred to Atrak clinic upper gastrointestinal endoscopy 
was proposed. At least 9 biopsies from the normal-looking esophagus and stomach 
were taken. Esophageal chromoendoscopy with 2% Lugol solution was performed and 
biopsies were taken from unstained mucosa. Unstained lesions were further examined 
for the presence of squamous dysplasia.  
For this study three sets of subjects were considered: early ESCC, esophageal 
squamous dysplasia, and mid-esophageal esophagitis. Those with squamous dysplasia 
and no evidence of cancer were included as squamous dysplasia subjects. 
Histopatholgically confirmed esophagitis in a biopsy sample from the mid-esophagus 
and without severe dysplasia or neoplasia were considered as subjects with mid-
esophagitis. Cancer cases included histopathologically confirmed ESCC with early 
stage (I, II). Healthy esophagus group consisted of endoscopy room patients who were 
referred to Atrak clinic with normal esophagus in all biopsies and without any 
malignancies.  
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4.3 DATA COLLECTION 
4.3.1 Questionnaire data  
Trained team of interviewers including a nurse, a physician, and a nutritionist 
administered structured general questionnaire and validated food frequency 
questionnaire (111). During the pilot phase from March 2002 to November 2003, 
interviewers were trained and questionnaires were tested for reliability and validity. To 
diminish inter-individual variation, a limited number of staff conducted the interviews. 
Interviews were conducted face-to-face interviews for cases and controls. No proxies 
were used for interview, though nutrition questionnaire was responded by a person who 
usually cooked at the home. Interview of case subjects was planned on the day of 
diagnostic upper gastrointestinal endoscopy at Atrak clinic. For each control individual, 
interview was done in the health houses or centers. Selected controls from Gonbad city 
were invited to a research facility established by DDRC for enrollment and follow up of 
a cohort study on upper gastrointestinal tract cancers and were interviewed (22). 
The general questionnaire covered questions on demographic variables, 
socioeconomic status, place of residence and its change, medical history and 
anthropometric measurements. For study I, we extracted data from questions on life-
long history of tobacco use (cigarettes, hookah, and nass). A detailed history was 
obtained including starting and stopping ages. Any change in amount and type of 
tobacco use was recorded. Ever users were those who had smoked, used, or chewed 
cigarettes, hookah, or nass at least weekly for a period of 6 months. Ever-tobacco-users 
were individuals who had done any of the above.  
The general questionnaire included questions on opium use. In Golestan province 
opium products included crude opium, refined opium extract, opium dross, and heroin. 
Opium users were defined as subjects who had consumed opium at least once per week 
for a minimum of 6 months. Users were then asked about type(s) of opiate used, the 
route of administration, the age they started and stopped using, and the amount they 
consumed. Any change in amount or type was recorded. 
Based on a cohort study and questionnaire data, alcohol consumption in the study area 
was uncommon (11). Subjects were asked about alcohol use and the amount and 
frequency of use as well.  
Trained physicians examined each patient’s oral cavity and teeth. Number of decayed, 
missing, and filled teeth (DMFT score) in addition to frequency of tooth brushing were 
recorded (80). 
Additionally, data on life-long history of exposure to four groups of domestic animals, 
equines, ruminants, canines and poultry was recorded during interview. A detailed 
history was obtained including starting and stopping ages and level of contact. Also any 
change in type of animal or level of contact was recorded. Level of contact was graded 
to 4 levels. Occasional contact with animals that were kept within 200 meters of 
residence or work place was graded as level one. Second level was defined as less than 
daily and once every 2 weeks contact with animals kept in the neighborhood or 
workplace. Daily contact with animals kept in residence place or neighborhood 
considered third level. Fourth level was graded for those who were responsible for jobs 
including feeding, cleaning or slaughtering animals on daily basis. 
The general questionnaire also collected detailed information on  potential 
confounders of interest.  
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4.3.2 Serology data 
Prior to endoscopy, 12 ml venous blood sample from each case subject was collected 
and its serum was stored serum at -80°C. Collected blood samples from matched 
controls were transferred on ice in a cooler box (~ 4°C). The time between collection 
and processing of neighborhood control samples was less than 12 hours. For those 
controls who were interviewed at the Golestan Cohort Center, sample processing and 
storage were performed immediately. 
 Serum pepsinogen I and II were measured using enzyme linked immunosorbent 
assays (ELISA) (Biohit, Finland). The conduction of serology was blinded toward case 
control status. Whereby matched sets (generally one case and 2 matched controls) were 
always placed on the same plate for ELISA. Aliquots from a pool of serum samples of 
healthy individuals were distributed among  assay plates (2 repeated samples per plate). 
H. pylori serology was evaluated qualitatively with Western Blot assay (Helico Blot 
2.1, Singapore). H. pylori infection was considered positive if (1) both 19.5 and 30 kDa 
bands were present or (2) any of the 35, 37, or 89 kDa band was present. CagA was 
positive if 116 kDa band was present. (Figure 2) 
 
 
Figure 2. CagA band categorization in the immunoblot test. The first band from right 
is CagA. Three strips from above to down includes: positive CagA band, faint band, 
and negative CagA band. 
 
 
We used validated cut-off points for diagnosis atrophy in the study population. The 
optimal cutoff value for serologic diagnosis of gastric fundal atrophy was PGI<55 µg/l 
with sensitivity and specificity of 61.9% and 94.8%, respectively. At cutoff 
concentration of 11.8 µg/l, PGII demonstrated 84.2% sensitivity and 45.4% specificity 
to distinguish non-atrophic pangastritis (45).  
 
4.3.3 16S rRNA sequence data 
DNA was extracted from equal length of frozen gastric tissue (5-6 mm) using 
DNeasy Blood & Tissue Kit (Qiagen, Inc., Valencia, CA). UV lamp exposure (for an 
hour with 15-20 cm distance from source) and centrifuge filtering through Amicon 
membrane (Millipore Co., Billerica, MA) were the method of decontamination. 
Mechanical and chemical lysis methods were applied to facilitate human cell and 
bacterial cell wall breakage. Tissues were treated with filtered-lysozyme in lysis buffer 
(Tris-EDTA-Triton) and overnight incubation at 56 
o
C in buffer AL (Qiagen, Inc., 
Germany) and proteinase K. Tissues were blended 100 µg glass beads (Tactum Lab, 
Sweden) with 0.1, 0.5 and 1 mm diameter for 1 minutes in Bullet Belender (BBX24, 
Next Advance, Inc., NY). Mixture was incubated with RNase (Qiagen, Inc., Valencia, 
CA). Tubes containing only beads, lysozyme, lysis buffer, and extraction kit substances 
were included as negative controls.  
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Small subunit of ribosomal RNA (16S rRNA) gene was amplified from extracted 
DNA by using a primer targeting region V3-V4. Forward primer (Bekt_341F: 5'-
CCTACGGGNGGCWGCAG) and reverse primer (Bekt_805R: 5'-
GACTACHVGGGTATCTAATCC) carried 454-adaptor sequences A and B (112). 
Unique 7 nt barcode for each sample was included in reverse primer in a way that 
barcodes differ in 2 nucleotides.  Polymerase chain reaction (PCR) included a mix 
containing 10ul 5X PCR buffer HF, 0.65 µl Phusion high fidelity DNA polymerase 
(New England Biolab Inc., MA), 1 µl PurePeak deoxyribonucleoside triphosphates 
(200 µM, ThermoScientific, Milwaukee), and 2.5 µl of each primer (10 µl, MWG 
eurofins, Germany). 1–2 µl of template DNA was added to this mix with total volume 
of 50 µl. GeneAmp PCR system 9700 cycler (Applied Biosystems, CA) was used with 
cycling parameters of initiation (95
o
C for 5 min), 30 cycles of denaturation (95
o
C for 
40 s), annealing (58
o
C for 40 s), and elongation (72
o
C for 1 min) with a final extension 
at 72
o
C for 7 min. Each sample was put in triplet with one negative control. Amplified 
products for each sample were pooled and verified by gel electrophoresis using 1% 
Agarose in TBE buffer. PCR products were purified by Agencourt AMPure XP 
magnetic beads (Beckman Coulter, Inc.,) with size selection through modifying PEG 
concentration to obtain 400-500 nt template. DNA concentration in each sample was 
measured using Qubit 2.0 fleurometer (Invitrogen Inc., UK). An amplicon pool was 
formed by pooling equimolar amounts of all DNA libraries for a minimum of 20 ng/dl. 
Pool amplicon was subsequently sent to SciLifeLab (Stockholm), where pooled DNA 
amplified in PCR-mixture-in-oil emulsions and sequenced on whole PicoTiterPlate 
(PTP) on GS-FLX Titanium  XLR-70 system (Roche Diagnostics Co., Sweden) . Plate 
was divided into 2 lanes and duplicate samples were run on both lanes.  
 
4.4 DATA ANALYSIS 
4.4.1 Studies I, II, IV 
For each of the exposures studied, average intensity, total duration, and cumulative 
use (average intensity multiplied by duration of use) were calculated. For study I, 
median amount in the control subjects was considered as the threshold to categorize 
tobacco and opium users as none, low use and high use. Age of first use was also 
categorized in a similar fashion.  
For study IV, total duration, average level of contact and intensity for each animal 
group (equines, ruminants, dogs, and poultry) were categorized into quartiles based on 
cut point levels among controls. Because exposure to more than one animal type was 
common, duration of contact was divided by the number of animal types.  
Conditional logistic regression models were used to calculate unadjusted and adjusted 
odds ratios (ORs) and 95% CIs. By design, case and control subjects were matched for 
age, sex, and place of residence. For study I, results were adjusted for education (as a 
marker of socioeconomic status) and ethnicity (Turkmen versus non-Turkmen). 
Additionally ORs (95% CIs) for different types of tobacco and opium use adjusted for 
each other, and for education, ethnicity, and total intake of fruit and vegetables was 
calculated. 
For study IV, results were adjusted for education (as a marker for socioeconomic 
status), ethnicity (Turkmen versus non-Turkmen), opium and tobacco use (four 
categories), fruit and vegetable use, alcohol consumption, source of drinking water 
(piped-water versus otherwise) and use of animal waste as fuel. 
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All statistical analyses were done using Stata Software (StataCorp, College Station, 
TX).  
In study II, PGI and PGII were analyzed as dichotomous variables using validated 
cutoff points. There was no a priori DMFT cutoff value. We used median DMFT 
among controls as a cutoff value for dichotomizing. Interaction on additive scale 
between dichotomous variables of gastric atrophy and poor dental health or oral 
hygiene habit was evaluated and the relative excess risk due to interaction, attributable 
proportion and synergy index were calculated. 
 
4.4.2 Study III 
4.4.2.1 Sequence data processing 
A pipeline developed by BILS (Bioinformatics Infrastructure for Life Sciences) on 
Uppmax (Uppsala Multidisciplinary Center for Advanced Computational Science) 
computational platform was used for computations. Standard flowgram files (*.sff) 
from each lane were split to individual samples and then samples with equal barcodes 
were joined. To filter noisy reads from sequences, AmpliconNoise v1.25 with its 
default filtering setting (PCR noise precision= 30, pyro noise precision= 0.6) was used. 
Chimeric sequences were removed applying Perseus based on comparing abundance of 
each chimeric sequence with its parents (113). All noise-free individual sequences were 
combined and clustered by applying complete linkage clustering algorithm in FCluster. 
Newly-shaped unique cluster of sequences were remapped to operational taxonomic 
unit (OTU) at similarity level of 93, 95, and 97% using nearest neighbor algorithm. At 
this stage those samples with lower than 1000 sequences were removed before 
subsampling of OTU matrices. Taxonomy hint(s) of each OTU cluster was identified 
using lowest common ancestor algorithm implemented in SINA aligner(114). Aligner 
was run against SILVA 111 reference database (115) through importing to ARB (116).  
 
4.4.2.2 Statistical analysis 
Estimate of microbial diversity was measured and compared between groups using 
species richness’ indices (Chao1 and Shannon). Squamous dysplasia and early 
esophageal cancer were treated as one disease group to improve the power of analysis. 
Assigned OTUs were compared individually between study groups using conditional 
logistic regression, and false discovery rate (FDR) control was used to correct for 
multiple comparisons. A minimum of eight discordant pairs was requested to include 
any OTU in the conditional logistic regression model. Beta diversity was estimated 
using Unifrac and weighted Unifrac distance based on abundance of OTUs. 
Community structure based on Unifrac distance was utilized to generate hierarchical 
dendograms to cluster individual samples. Principal coordinate analysis (PCoA) was 
applied to ordinate dissimilarity matrices. Conditional logistic regression model was 
used to compare first 10 coordinates between groups of study subjects. Akaike 
information criterion (AIC) was used to select a best-fit model. Calculations and 
statistical analysis were performed using  R (www.r-project.org) and phyloseq package 
(117, 118).  
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4.5 VALIDATION STUDY  
Definitive gastric atrophy diagnosis through gastro-endoscopy and histology 
examination requires invasive clinical intervention. Yet, histology examination of 
tissue biopsies may be subject to error due to patchy nature of atrophy and the 
limitation in the number of biopsies (119). There was no previously validated threshold 
for serologic diagnosis of gastric fundal atrophy in our study population. To study 
gastric atrophy association with ESCC, a valid criterion for assessment of exposure was 
needed to minimize misclassification of atrophy.  
We performed a study to evaluate the validity of serologic diagnosis of fundic 
atrophy by examining the levels of PGI, PGII, PGI/PGII ratio versus histology among 
patients who were visited endoscopy clinics in the eastern Golestan province (45).  
All dyspeptic patients older than 50 years old visiting consecutively the endoscopy 
clinics located in Gonbad city between April 2007 and August 2008 were enrolled in 
the study. Patients with a history of malignancies were excluded. Before performing 
endoscopy and after an overnight fast, five ml blood was taken and serum aliquots were 
kept at -80
o
C. Five biopsy specimens were taken from the greater curve and posterior 
wall in mid-antrum and mid-corpus plus incisura angularis and were submitted to the 
Digestive Disease Research Center laboratory for histologic examination using  
updated Sydney System criteria (120).  
Inflammation, intestinal metaplasia, and atrophy were assessed and graded as mild, 
moderate or marked. We grouped combined moderate or marked atrophy as atrophic 
group and mild or no atrophy was grouped as non-atrophic. We classified marked or 
moderate gastritis as pangastritis when biopsies from corpus and antrum or corpus and 
incisura angularis were diagnosed with non-atrophic gastritis. Blind to histology results 
we measured serum PGI and PGII by using ELISA (Biohit, Finland) at the Swedish 
Institute for Infectious Disease Control (SMI).  
 “Receiver operating characteristic (ROC) curves were constructed using different 
combinations of sensitivity and specificity, and the areas under the curves (AUCs) and 
their 95% CIs were calculated. Youden index was calculated to choose the optimal 
cutoff value that confirmed the diagnosis of fundic atrophy with a FPF ≤ 20% - 
30%.”(45) 
Among 309 enrolled subjects, the best cutoff values for serologic diagnosis of fundic 
atrophy were PGI < 55 µg/l and PGI/PGII ratio < 5. Due to the high prevalence of 
pangastritis which might affect pathology gold standard, we restricted study samples to 
those without serologic pangastritis (PGII < 11.8 µg/l). The sensitivity of using PGI < 
55 µg/l to define fundic atrophy improved to 83.3% (95% CI: 51.6 - 97.9) among those 
with PGII < 11.8 µg/l (Table 1). 
 
4.6 SENSITIVITY ANALYSIS 
In study II, we observed an elevated risk of ESCC associated with pepsinogen II. 
From validation study we learned that presence of pangastritis could decrease the 
diagnostic accuracy of PGI. We linked this association to the possibility of gastritis 
secondary to ESCC. Gastric biopsy for majority of neighborhood controls was not 
available as less than 10% of them visited our clinic afterwards. The best that we could 
do was to compare gastritis in the histology of ESCC cases to endoscopy room controls 
and observed a 2-fold elevated risk of ESCC among those with pangastritis. From 
validation study we learned that presence of pangastritis could decrease the diagnostic 
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accuracy of PGI for atrophy detection and possibly cause misclassification. To quantify 
the magnitude of such bias, we estimated the classification probabilities using external 
validation study (45). Effects of the range of PGII levels (as a marker of pangastritis) 
on diagnostic accuracy of PGI and ORs for the association with ESCC were tested. We 
found that when proportion of cases and controls with pangastritis differs, the estimate 
would be exaggerated if mostly ESCC cases have pangastritis and it would be if 
pangastritis would be dominant among controls. 
 
Table 1. Screening characteristics of pepsinogens for diagnosis of fundic atrophy and 
non-atrophic pangastritis. 
Cutoff value 
Sensitivity  
(95% CI) 
Specificity  
(95% CI) 
AUC  
(95% CI) 
Fundic atrophy 
   
PGI < 55 μg/l 61.9 (38.4 - 81.9) 94.8 (91.6 - 97.1) 0.78 (0.68 - 0.89) 
PGII  > 11.8 μg/l 40.0 (19.1 - 63.9) 34.0 (28.6 - 39.8) 0.37 (0.26 - 0.48) 
PGI/PGII <  5 75.0 (51.0 - 91.3) 91.0 (87.0 - 94.0) 0.83 (0.73 - 0.93) 
PGI < 55 and  PGI/PGII < 5 60.0 (36.1 - 80.9) 97.2 (94.6 - 98.8) 0.79 (0.68 - 0.90) 
Non-atrophic pangastritis 
   
PGII > 11.8 μg/l 84.2 (75.6 - 90.7) 45.4 (38.5 - 52.5) 0.65 (0.60 - 0.70) 
PG: pepsinogen, AUC: area under curve. Table is reproduced with modifications from 
a published article by the author (45) 
 
 
4.7 ETHICAL CONSIDERATION 
The study was approved by the Ethical Committee of the Digestive Disease Research 
Centre of Tehran University of Medical Sciences, Iran and the Institutional Review 
Board of National Cancer Institute, US and the Stockholm Regional Ethics Vetting 
Board, Sweden. 
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5 RESULTS 
5.1 SUBJECTS 
A total of 300 ESCC case subjects were enrolled in this study. Of these, 271 had two 
matched controls and 29 had one matched control (Table 2). 
 
Table 2. Demographic characteristics of study subjects (table content was reproduced 
from a previously-published paper (26) by author with permission from publisher) 
 
 ESCC cases (%) Matched controls (%) 
Total  300 (100) 571 (100) 
Age (years)   
    ≤ 50 
    51 – 60 
    61 – 70 
    > 70 
 
32 (11) 
81 (27) 
86 (29) 
101 (34) 
 
61 (11) 
144 (25) 
177 (31) 
189 (33) 
Gender  
    Male 
    Female 
 
150 (50) 
150 (50) 
 
278 (49) 
293 (51) 
Place of residence 
    Urban 
    Rural 
 
82 (27) 
218 (73) 
 
150 (26) 
421 (74) 
Ethnicity 
    Turkmen 
    Non-Turkmen 
 
171 (57) 
129 (43) 
 
312 (55) 
259 (45) 
ESCC: Esophageal squamous cell carcinoma 
 
5.2 STUDY I 
 In total 30% of ESCC cases and 18% of the matched controls reported that had ever 
used opium. Opium use was less among women as 27% of men and 11% of women 
had ever used opium. Approximately 70% of opium users were living in rural areas.  
Table 3 shows the results of variables for opium use when study subjects were limited 
to those who started using opium earlier than one year prior to diagnosis, and the 
adjusted OR (95% CI) for ever use of opium was 1.92 (1.30 - 2.84).  
The habit of ever smoking cigarettes was associated with a 1.47 (95% CI = 0.98 – 
2.21) elevated risk of ESCC. Grouping cigarette smokers, hookah and nass users as 
tobacco users resulted in an OR of 1.85 (95% CI= 1.27 – 2.68) for ESCC risk. The 
nearly-significance risk was resulted when adjustment for opium was done (OR=1.50, 
95% CI = 0.99 -2.28). In total, 7% of ESCC cases reported ever smoking hookah and 
among them, those who smoked hookah more than 3 times per day showed a 3-fold 
elevated risk for ESCC. Habit of chewing nass was reported by 15% of ESCC cases 
and in a model which included hookah and cigarette use, chewing nass was associated 
with 3-fold increase in ESCC compared to tobacco-non users. Adjustment for opium 
decreased the risk to 2-fold. 
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In all 21 subjects, 7 cases (2%) and 14 controls (2%) reported to have ever used 
alcohol for six months or more. Due to the small number of exposed subjects- based on 
questionnaire- we did not detect any risk associated with alcohol. 
When we examined any tobacco or opium use, alone or together, compared to using 
neither (Table 4), tobacco use alone, opium use alone, and a combination of the two 
were all significantly associated with higher ESCC risk. 
 
Table 3. Opium consumption and risk of ESCC (after exclusion of those who had 
started tobacco or opium use a year before diagnosis) 
1
Adjusted for education and ethnicity.  
2
Adjusted for education, ethnicity, total intake of fruit and vegetables, alcohol 
consumption, and tobacco use.  
ESCC: Esophageal squamous cell carcinoma. 
 
Table 4. Opium and tobacco consumption and risk of ESCC (we excluded those who 
had started tobacco or opium use a year before diagnosis) 
1
Adjusted for education, ethnicity, total intake of fruit and vegetables, and alcohol 
consumption.  
ESCC: Esophageal squamous cell carcinoma. 
 
 Unadjusted OR (95% CI) Adjusted
1 
OR (95% CI) Adjusted
2
 OR (95% CI) 
Opium use 
    Never 
    Ever 
 
Referent 
1.92 (1.30 - 2.84) 
 
Referent 
1.96 (1.32 – 2.91) 
 
Referent 
1.69 (1.08 - 2.65) 
Duration  
     Never used 
     ≤ median  
     > median 
 
Referent 
1.03 (0.54 - 1.97) 
2.44 (1.57 - 3.80) 
 
Referent 
1.06 (0.55 - 2.03) 
2.52 (1.61 - 3.96) 
 
Referent 
1.02 (0.52 - 2.00) 
2.17 (1.29 - 3.64) 
Amount 
     Never used 
     ≤ median  
     > median 
 
Referent 
1.32 (0.76 - 2.32) 
2.46 (1.51 - 4.00) 
 
Referent 
1.33 (0.75 - 2.34) 
2.61(1.59 - 4.30) 
 
Referent 
1.25 (0.70 - 2.26) 
2.25 (1.26 - 4.01) 
Intensity 
     Never used 
     ≤ median  
     > median 
 
Referent 
1.36 (0.80 - 2.32) 
2.56 (1.54 - 4.26) 
 
Referent 
1.35 (0.79 - 2.31) 
2.74 (1.63 - 4.61) 
 
Referent 
1.24 (0.70 - 2.20) 
2.38 (1.31 - 4.33) 
Start age 
     Never used 
     ≤ median  
     > median 
 
Referent 
2.60 (1.68 - 4.04) 
0.74 (0.35 - 1.54) 
 
Referent 
2.73 (1.74 - 4.28) 
0.74 (0.35 - 1.56) 
 
Referent 
2.43 (1.45 - 4.08) 
0.70 (0.32 - 1.51) 
 Unadjusted OR (95%CI) Adjusted
1 
 OR (95% CI) 
Opium and tobacco 
Used neither tobacco nor opium 
Used tobacco but not opium 
Used opium but not tobacco 
Used both tobacco and opium 
 
Referent 
1.67 (1.03 - 2.68) 
2.12 (1.11 - 4.04) 
2.17 (1.36 - 3.47) 
 
Referent 
1.67 (1.03 - 2.71) 
2.02 (1.05 - 3.88) 
2.31 (1.43 - 3.72) 
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5.3 STUDY II 
Study subjects were the same as study I. Serum samples were available for 293 (98%) 
cases and 524 (92%) controls. For those cases with available serum samples, at least 
one matched control existed. Demographic characteristics of the study participants and 
potential confounders are summarized in the Table 5. No substantial differences were 
observed between those who provided serum and those whose serum samples were not 
available. 
 
Table 5. Characteristics of ESCC cases and matched controls with available serum 
samples. (Table content was reproduced after modification from a previously-published 
paper(121)  by the author with permission from publisher) 
 
Characteristics 
Controls  
(n=524) 
ESCC cases  
(n=293) 
Controls without  
serum samples (n=47) 
p value
1
 
Mean age (SD), years 65.5 (10.4) 64.4 (11.1) 62.1 (9.9) 0.07 
Sex (%) 
 
 
  
Men 256 (48.8) 147 (50.2) 22 (46.8) 0.8 
Women 268 (51.2) 146 (49.8) 25 (53.2) 
 
Fruit and vegetable  
consumption (%) 
  
  
≤ median  235 (44.8) 139 (47.4) 20 (42.5) 0.76 
> median 289 (55.1) 154 (52.6) 27 (57.5) 
 
DMFT (%)
2
 
 
 
  
≤ median (28) 266 (51.0) 117 (40.3) 28 (59.6) 0.25 
> median 256 (49.0) 173 (59.7) 19 (40.4) 
 
Tooth brushing habit      
Ever 221 (42.4) 59 (20.3) 18 (39.1) 0.66 
Never 300 (57.6) 232 (79.7) 28 (60.9)  
DMFT: Sum of decayed, missing, and filled teeth. 
1
p value for significance of 
difference between controls with and without serum samples. 
2
Numbers of cases and 
controls were less than total because of missing data. 
 
Using validated cutoff for serologic diagnosis of gastric atrophy showed that PGI < 
55µg/l was associated with a 1.39-fold non-significant elevated risk of ESCC (95% CI: 
0.93 - 2.09). Other published cutoff values i.e. PGI < 30 µg/l, PGI/PGII < 3, PGI <70 
µg/l and PGI /PGII ratio < 3 did not change the point-estimate materially. Whereby, 
combination of PGI/PGII ratio <5 and PGI< 55 µg/l, was associated with a significant 
1.62-fold increased risk of ESCC (95% CI = 1.01 – 2.65). Excluding those who 
reported ever use of proton pump inhibitors did not change the estimates. Based on our 
validation study results, diagnostic ability of PGI alone was as god as its combination 
with ratio.  
Furthermore we observed a group of ESCC cases and controls (13 cases and 7 
controls) with extremely high level of PGI ( >250 µg/l) or PGII (> 60 µg/l). This group 
rendered an OR of 3.08 (95% CI = 1.20 – 7.90) for ESCC risk. The best we could 
conclude of the presence of this group was the possibility of a high inflammation 
(gastritis) in our study subjects.    
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We stratified two groups of fundal atrophy (defined by PGI < 55 µg/l ) by level of 
PGII. As we reported earlier, PGII > 11.8 µg/l was a marker of severe pangastritis in 
the study population. We did not detect any elevated ESCC risk associated with gastric 
atrophy among those with pangastritis. We combined marker of severe non-atrophic 
pangastritis with PGI and evaluated association between gastric fundal atrophy with 
ESCC because we assumed that gastritis might be caused secondary to ESCC. 
Combination of PGI < 55µg/l and PGII < 11.8µg/l was associated with a 2-fold 
increased risk for ESCC (Table 6).  
 
Table 6. Serologic gastric fundal atrophy association with ESCC. 
  
Controls 
(%) 
ESCC cases 
(%) 
Adjusted 
1
OR 
(95% CI) 
Serologic fundal atrophy and non-atrophic 
pangastritis 
      
PGI  ≥ 55 & PGII2 < 11.8 189 (36.1) 71 (24.2) Referent 
PGI  < 55 & PGII  < 11.8 57 (10.9) 42 (14.3) 2.01 (1.18 - 3.45) 
PGI  ≥ 55 & PGII  ≥ 11.8 260 (49.6) 167 (57) Referent 
PGI  < 55 & PGII  ≥ 11.8 18 (3.4) 12 (4.4) 1.20 (0.54 - 2.66) 
1
Adjusted for education, ethnicity, fruit/vegetable use, and tobacco/opium consumption. 
2
For one case PGII was missing. 
 
H. pylori infection serology, measured as antibodies against some H. pylori antigens 
implemented in immunoblot kit was not associated with ESCC risk. In total CagA band 
was detectable (including faint bands) in 90% of controls and 88% of ESCC cases. We 
were unable to detect an association between H. pylori and ESCC in our study samples 
by using this particular immunoblot kit (Table 7). 
 
Table 7. Adjusted
1
 OR (95%CI) for association of H. pylori and ESCC risk.  
 
Reference: H. pylori-  H. pylori+CagA- H. pylori+CagA+ 
H. pylori status
2
 
   
H. pylori-  1 1.3 (0.7-2.4) 0.7 (0.4-1.2) 
H. pylori+ CagA- 0.7 (0.40-1.37) 1 0.5 (0.3-1.1) 
H. pylori+ CagA+ 1.3 (0.82-2.12) 1.8 (0.9-3.5) 1 
1
 Adjusted for ethnicity (non-Turkmen or Turkmen), alcohol consumption, tobacco or 
opium use, education level, fruit and vegetable use. 
2
H. pylori was considered positive if (1) both 19.5 and 30 KD were present or (2) any 
of the 35, 37, or 89 KD band was present. CagA was positive if 116 KD band was 
accompanied by any of the above- mentioned bands. 
 
To test for possible biologic synergism between poor oral health and gastric fundal 
atrophy, we tested the additive interaction. Due to low power, we broke the matching 
frame and added the matching factors (age, gender, rural or urban residence) to an 
unconditional logistic regression model. Adjusted OR for association of DMFT with 
ESCC was 1.60 (95% CI: 1.14 - 2.24) (Table 8).  
Based on small number of cases, presence of poor dental hygiene, indicated as higher 
than median DMFT, and gastric atrophy rendered a more than 4-fold excess risk of 
ESCC compared with the reference group. The relative excess risk due to interaction 
 20 
between low poor dental hygiene and fundal atrophy was 1.47 (95% CI: -1.15 - 4.1), 
synergy index (95% CI) was 1.90 (0.6 - 6.1), and the attributable proportion (95% CI) 
was 0.36 (-0.14 - 0.85) (Figure 3).  
To test if the finding was dependent on our particular criteria for dental hygiene, we 
used frequency of tooth brushing as another measure of oral hygiene. Frequency of 
tooth brushing in combination with fundal atrophy resulted in an 8-fold increase in 
ESCC risk (OR = 8.65, 95% CI: 3.65 - 20.46). 
 
Table 8. OR (95% CI) for the association between DMFT and ESCC comparing 
different choices of categories of DMFT 
  OR (95% CI) Adjusted
1
 OR (95%CI) 
DMFT number     
0-10 Referent Referent 
11-20 1.68 (0.78 - 3.58) 1.89 (0.86 - 4.20) 
21-30 2.14 (1.03 - 4.44) 2.07 (0.96 - 4.49) 
31-32 3.30 (1.58 - 6.90) 3.16 (1.45 - 6.92) 
DMFT median     
< median (28) Referent Referent 
≥ median  1.77 (1.27 - 2.46) 1.60 (1.14 - 2.24) 
DMFT Centiles     
1st (≤ 18) Referent Referent 
2nd (19-25) 1.73 (1.03 - 2.91) 1.63 (0.95 - 2.79) 
3rd (26-31) 2.26 (1.37 - 3.74) 1.90 (1.12 - 3.22) 
4th (32) 2.49 (1.54 - 4.04) 2.23 (1.35 - 3.69) 
1
 Adjusted for ethnicity (non-Turkmen or Turkmen), alcohol consumption, tobacco or 
opium use, education level, fruit and vegetable use. 
DMFT: Decayed, missing, filled teeth. ESCC: Esophageal squamous cell carcinoma 
 
The relative excess risk due to interaction between habit of never brushing teeth and 
atrophy was 4.34 (95% CI: -1.07 - 9.76), synergy index 2.24 (95% CI: 0.97 - 5.15), and 
attributable proportion 0.49 (95% CI: 0.14 - 0.83). Based on fewer sets, conditional 
logistic regression model showed similar results. 
 
Figure 3. Joint effect of poor dental health and gastric atrophy on ESCC risk. 
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5.4 STUDY III 
5.4.1 Subjects 
Of 579 non-cancerous subjects who were referred to Atrak clinic, 18 with squamous 
dysplasia and no evidence of cancer were diagnosed. We found 19 ESCC patients in 
early clinical stages. For each subject with a diagnosis of dysplasia or early stage 
cancer, one age- and sex-matched control was randomly selected from subjects with a 
healthy esophagus from endoscopy clinic controls. We also tried to select subjects with 
a diagnosis of esophagitis in the mid esophagus as a separate control. During study 
period, a total of 17 age- and sex-matched esophagitis control subjects could be 
identified. As our multiplexing method was optimized for 95 samples, we added 2 more 
subjects with mid-esophagitis and their age- and sex-matched controls. Esophagitis had 
been considered to be extremely high (80%) in the high risk areas of Linxian and 
Gonbad in two reports (122, 123). Histology criteria for diagnosis of esophagitis was 
based on more recent publication (124) which was different from early criteria and 
estimated prevalence of esophagitis was around 5%. Prevalence of esophagitis and 
squamous dysplasia in our study sample was in accordance with reports from high risk 
areas for ESCC (125). 
The mean age (SD) of ESCC and squamous dysplasia was 64.5 (11.8), for controls 
63.4(14.6) and for mid-esophagitis was 62.1(16.3). Fifty-one percent of ESCC and 
squamous dysplasia subjects were men. 
 
5.4.2 Sequence data 
After combining two lanes of 454 sequencer, 369, 539 sequences with mean length of 
419 nt were obtained from 93 gastric tissue samples. Average sequence per sample was 
3,004. A total of 25% of sequences were removed as noise or chimera. Two samples 
had less than 1000 reads (504 and 710 reads) and were excluded. As a result, 36 
matched pairs of esophageal cancer/dysplasia-healthy control and 17 pairs of matched 
mid-esophagitis-healthy control were left. After clustering unique sequences at 3%, 
5%, and 7% of dissimilarity rate, 2075, 1636, and 1300 OTUs were shaped. Based on 
SILVA database (release 111) theses OTUs could be represented by 1283 bacterial 
taxa. OTUs which could not be assigned, were considered unclassified. Majority of 
these unclassified OTUs (80%) were singleton (n = 517) and double tone (n = 123). At 
the sample level, highest numbers of unclassified OTUs were observed in 2 samples 
with 8.5% and 2.9% of total OTUs. Mean percentage of unknown OTUs per sample 
after excluding these 2 subjects was 0.5%. 
Figure 4. depicts gastric mucosa-associated microbiota representatives at the Phylum 
level in subjects with mid-esophagitis, ESCC plus squamous dysplasia and normal 
esophagus (126). Observed cumulative, and mean value of species richness over 
samples were 1308, 117.6 for the esophageal cancer or dysplasia group, 1154, 100.7 for 
control group, and 626, 84.5 for mid-esophagitis group respectively. Comparison of 
OTU richness, measured by mean Chao1 showed similar results for the esophageal 
cancer or dysplasia group versus control group (p = 0.4) and non-significantly lower for 
mid-esophagitis (p = 0.06). 
OTUs were assigned to 31 phyla, 53 classes, 90 orders, 168 families, and 336 genera.  
Five most abundant phyla were Firmicutes, Bacteroidetes Proteobacteria, 
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Actinobacteria, and Fusobacteria. Phyla composition was consistent across esophageal 
cancer or dysplasia, control and mid-esophagitis groups. 
After ordination of dissimilarity measurements based on Unifrac and weighted-
Unifrac distance using PCoA, conditional logistic regression model was applied to 
compare study groups. A significant difference in Unifrac distance between ESCC or 
squamous dysplasia group and controls in the three coordinates was observed 
(p=0.003).  First coordinate based on weighted-Unifrac dissimilarity index, explained 
60% of variance and differs significantly two groups (p =0.018). Similar results were 
obtained when matched analysis was based on multidimensional scaling ordination 
using Unifrac (p=0.005), and weighted-Unifrac (p=0.016).  
After excluding early cancer patients and restricting conditional logistic regression 
analysis to squamous dysplasia, results did not change substantially. Results on 
comparing dissimilarity distances between mid-esophagitis and ESCC or squamous 
dysplasia subjects were not suggestive of significant difference (PCoA ordination on 
weighted Unifrac distance: p=0.463) 
 
Figure 4. Gastric mucosa-associated microbiota composition at Phylum level with 
probable phylogenetic match among a pool of subjects with mid-esophagitis, 
esophageal squamous cell carcinoma and dysplasia, and with normal esophagus. 
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5.5 STUDY IV 
The study included 300 incident case patients and 571 matched control subjects from 
whom animal contact history was available for 287 (96%) cases and 542 (95%) 
controls.  Of the 42 subjects (13 cases, 28 controls) with missing history of animal 
contact 18 case-control pairs were missing due to lack of information on cases in 13 
pairs and lack of exposure data on controls in 5 pairs. For the rest of subjects with 
missing data, at least one control for each matched-pair existed. A total of 19 subjects 
(11 controls and 8 ESCC cases) reported to have contact with more than one animal 
type without further specification; there was no association with risk of ESCC among 
them (OR = 1.87, 95% CI: 0.62 - 5.69) and they were excluded when association with 
particular type of animal was investigated. No substantial difference was observed 
between subjects with available and missing history of exposure to animals considering 
demographics and confounders. 
There was no difference between men and women in terms of contact with four types 
of animal. Contact with ruminants was associated with an eight fold increased risk of 
ESCC (95% CI: 4.40 -15.44) (Table 9). We observed a significant excess risk 
associated with contact with dogs among ESCC patients (OR = 1.92, 95% CI: 1.35 - 
2.72). When exposure to ruminants and dogs, alone or in combination was considered, 
the adjusted OR (95% CI) for dog contact alone was 3.82 (1.00 - 14.63). 
Exposure to different animals overlapped among participants. We compared exposure 
to 2, 3 and 4 different types of animals with exposure to only one type as a reference 
group. The observed excess risks were constant through different strata without obvious 
trend. 
 
                Table 9. Animal contact and risk of  ESCC. 
  Controls (%) Cases (%) Adjusted
1 
OR (95% CI) 
Equines    
Never 234 (44.1) 121 (43.1) Referent 
Ever 297 (55.9) 160 (56.9) 0.92 (0.66 - 1.29) 
Ruminants    
Never 166 (31.3) 15 (5.3) Referent 
Ever 365 (68.7) 266 (94.7) 8.24 (4.40 - 15.44) 
Domestic canines    
Never 251 (47.3) 82 (29.2) Referent 
Ever 280 (52.7) 199 (70.8) 1.92 (1.35 - 2.72) 
Poultry    
Never 69 (13.0) 35 (12.5) Referent 
Ever 462 (87.0) 246 (87.5) 1.06 (0.63 - 1.78) 
 
1
Adjusted for potential confounders including education (as a proxy for socioeconomic 
status), ethnicity (Turkmen versus non-Turkmen), opium and tobacco use (four 
categories), fruit and vegetable use, alcohol consumption, source of drinking water 
(piped water versus otherwise) and use of animal waste as fuel. 
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6 DISCUSSION 
6.1 METHODOLOGICAL CONSIDERATION (design, bias, confounding) 
Esophageal cancer is a rare disease and case-control design is an efficient way to 
study several exposures in a limited period of time for this cancer. Due to sharp 
geographic boundary of high incident area for esophageal cancer in northern Iran, 
source population was defined as those who were inhabitants of the eastern Golestan 
province. Cancer registry data showed that approximately 70% of incident cases in 
source population were enrolled in this study. For control selection, random sampling 
from source population was not feasible at the time of study and risk of cancer within 
catchment area varied by geographical regions (3). One convenient way was to sample 
controls who were individually matched to cases from the same neighborhood. 
Although not all incident cases in the source population were enrolled, neighborhood 
controls still constituted a useful control series (127). As physicians in the study 
catchment area were asked to refer their patients suspected of having upper 
gastrointestinal tract cancers to the enrolling clinic, there is no evidence that 
neighborhood controls may include people who would not have visited the same clinic 
had they developed the disease under study. Matching might improve efficiency in 
some degrees (128) but also it has some disadvantages (129). 
In study IV, animal contact was the exposure of interest and matching on 
neighborhood could potentially provide a more efficient stratified analysis (130) when 
confounders such as source of pasture for grazing or exposure of farm animals to 
pesticides and herbicides varied regionally and have numerous categories. In study III 
matching on age and probably sex, improved power of this study with small sample 
size as age and gastrointestinal microbiota are linked (131). On the other hand, the 
effort which had been made to find matched controls probably resulted in decreased 
number of controls per case, thus it might not be a cost efficient method. 
In study II, processing time of blood samples from neighborhood controls was longer 
than cases due to the distance from study center. However efforts were made to transfer 
whole blood at 4
o
C, if whole blood storage conditions affect pepsinogen level 
measurement, it would bias the results. We compared pepsinogen levels in sera of 
controls from areas close to processing center and areas located in long distance and did 
not observe significant difference.  
Biologic specimen in study II and III were collected at the time of cancer diagnosis. 
In study III, the observed microbiota pattern in stomach might be secondary to changes 
in esophageal cancer, although we observed similar pattern in stomach of those with 
esophageal squamous dysplasia. In study II, majority of subjects were diagnosed at 
advanced stages of ESCC, though induction period for esophageal cancer is probably 
shorter than that for gastric atrophy development, reverse causality is unlikely. 
In study I, people in Golestan may start using opiates to alleviate pain prior to their 
cancer diagnosis and therefore reverse causality is a concern. However, excluding the 
subjects who had recently (one year before diagnosis or enrollment) started using 
opium from the analysis made no material difference in the study results, and younger 
age at first use was a strong predictor of cancer risk. Selection bias due to non-
participation of controls is ignorable as 77% of the enrolled controls were the first 
randomly selected individuals and 11 and 3% were the second and third choices (110). 
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Although diagnosis of esophageal cancer is not difficult and it is estimated that 90% 
of tumors were of squamous origin in the study area, 100% of the cases in this study 
had pathological confirmation of ESCC and misclassification of outcome is unlikely. 
The possibility of misclassification of exposure in study I was declined by performing 
validation study (132) which showed high validity and reliability of questionnaire to 
assess opium consumption. In study II, laboratory experiment was designed in a blind 
manner to the case/control status and matched sets were analyzed in the same plate. 
However misclassification of H. pylori status would be of concern due to 3 main 
factors: (1) the immunoblot kit was not validated for the population under study, (2) the 
immune response in cancer patients to H. pylori antigens might have changed due to 
change in nutrition and malignancy status, (3) precise history of H. pylori eradication 
was not available from study subjects. 
Low sensitivity for atrophy detection might lead to loss of precision and power by 
unnecessary reducing the exposed sample size. However, we chose atrophy cutoff point 
at high specificity level (97%), false negative probability of 0.4 in addition to low 
prevalence of gastric atrophy in the population could potentially result in 
misclassification of exposure among cases and controls which we believe if evolves it 
would be differential. False negative results are inherent in serologic diagnosis of 
atrophy due to the low sensitivity of the diagnostic method. It is believed that resulted 
misclassification will drive the association toward null if non-differentiality assumption 
is met. However atrophy is an uncommon exposure and its binary value is the result of 
categorizing continuous PGI variable. Our results of sensitivity analysis confirmed that 
there is an effect of misclassification due to ignoring non-atrophic pangastritis on 
association between atrophy and ESCC. We used PGII as a marker of severe 
inflammation as stratifying factor to decrease this effect. 
In study III, contamination of biopsy samples might be of concern, however we made 
all efforts to avoid it by using Ultraviolet light and filtering the solutions. Sequencing 
errors and PCR chimera formation were corrected by using noise removal pipelines. 
Although microbial community assessment based on 16S rRNA gene sequencing is 
useful in bacterial classification, it has low phylogenetic power at the species level 
(133). Furthermore, V4 and V5 are less specific for species level (134) and we avoided 
assigning genus or species nomenclature to the OTUs. Although 16S is a gold standard 
of bacterial phylogeny, presence of its multiple copies in some bacteria with slight 
difference in sequence could lead to identifying multiple types of the same bacterium 
(135, 136) which might have resulted in misclassification of exposure. In our data 
unassigned OTUs were unevenly distributed among samples, as five samples shared 
most of those. These rare species could be formed due to intrinsic errors of 
pyrosequencing (137). 
Recall bias, which is common in exposure assessment based on questionnaire, is a 
source of concern in study I and IV. Neither interviewers nor study subjects were aware 
of study hypothesis about animal contact and opium consumption as potential risk 
factors. 
Detailed information on potential confounders was collected during this study which 
let us to adjust for several factors.  
In study II, our statistical inference on presence of interaction between poor oral 
hygiene and gastric atrophy had low precision due to the modest sample size. In study 
III, accuracy of our estimate for alpha diversity is questionable due to number of 
denoised sequences (138). Although our studies were among the largest up to date, the 
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sample size in study III is small. The cost of increasing sample size in 454 sequencing 
platform would result in lower depth of sequencing. Newer version of next generation 
sequencing platforms will provide deeper reads with higher number of samples. 
 
6.2 INTERPRETATION OF FINDINGS 
6.2.1 Opium consumption and risk of esophageal squamous cell 
carcinoma 
Opium was common enough in study area at the time that most of our study subjects 
had started consuming opium (about 40 years ago). Long term opium use at low doses 
was the common feature of its consumption among this population. Opium 
consumption is associated with a stigma among populations and this might limit the 
validity of questionnaire responses. For reliability of the questionnaire, a subset of rural 
and urban residents in the catchment area were interviewed twice about ever use of 
opium. An agreement between responses to opium questions in our questionnaire for 
ever use of opium was 0.99 and the corresponding kappa statistic was 0.96 (11). 
We tested the validity of self-reported current use of opium by measuring codeine or 
morphine in the urine. It was found that self-report of current opium use had a 
sensitivity of 0.93 and specificity of 0.89 (132). However we were not able to test the 
validity of questionnaire on duration or amount of opium use, we decided to use 
questionnaires to measure opium use as the exposure. The percentage of opium users 
among control subjects found in this study is close to the percentage found in the 
50,000 subjects enrolled in a cohort study among the same source population (11, 22). 
The results of our study showed a 2-fold increased risk of ESCC associated with opium 
use. Similar odds ratio was obtained when we restricted the analysis to tobacco non-
users. 
The results of this study showed that consumption of both crude and refined opium 
are associated with increased risk of ESCC. Both routes of administration, smoking and 
ingesting, were associated with an elevated risk of ESCC. Whereby inhaling opium 
smoke might be linked to the PAH exposure, similar risk of ESCC for ingesting opium 
does not fully consistent with this hypothesis. A recent study in the same population 
has reported that opium might have a role in gastric cancer carcinogenesis as it was 
associated with more than 3-fold increase in gastric adenocarcinoma risk with a dose-
response relationship (139) which is even higher than the risk we observed for ESCC. 
Esophageal cancer and gastric cancer are the two most common malignancies in the 
study area and observing an association with opium is plausible. While decline in 
opium use during recent decades is in line with decline in ESCC incidence, the 
prevalence of gastric cancer is increasing in the study area.   
Limited number of animal studies on carcinogenic effect of opium did not show 
persistent results. A case-control study with hospital controls in the same area did not 
detect association between opium and ESCC risk (140). A prospective study on cause 
of death among 50,000 individual recruited in a cohort study in Golestan province, did 
not show a significant hazard ratio for ESCC mortality among men who used opium. 
Although, the hazard for ESCC mortality was more than 2-fold among women who 
ever used opium (141) . One may raise this possibility that opium per se might not be a 
carcinogenic agent for ESCC; rather the reason that users consumed opium might be 
the main risk factor. As in the study area opium has been mostly used as a medication 
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for gastrointestinal and upper respiratory infectious diseases, it might be a proxy for 
lifelong history of certain infectious diseases. Opium was significantly elevated hazard 
of death due to infectious diseases by 9-fold (141). 
Cigarette smoking is a major risk factor for ESCC in low incident areas, we found a 
weak to moderate association between cigarette smoking and ESCC in eastern 
Golestan.  It is likely that smoking is not a strong risk factor for ESCC in this 
population because incidence of ESCC is similar among men and women in the study 
area but smoking prevalence among rural women is 1% and among urban men is 39%. 
Weak association between smoking and ESCC risk may also be due in part to the 
relatively low cumulative tobacco exposure among the smokers; as median cumulative 
use among the smoking controls in this study was 13.5 pack-years.  
In our study, although the confidence intervals are wide, the point estimates suggest 
that smoking hookah and chewing nass are at least as strong risk factors for ESCC as 
cigarette smoking. The intensity and duration of nass use showed a dose-response 
association with ESCC risk. We did not detect a trend for duration of hookah use. This 
might be partly due to some people changing from hookah use to cigarettes.   
 
 
6.2.2 Gastric fundal atrophy and risk of esophageal squamous cell 
carcinoma 
Serologic gastric atrophy, as indicated by low serum pepsinogen, in the absence of 
severely inflamed gastric tissue was associated with an increased risk of ESCC. We 
used serum pepsinogens for measurement of exposure however, pepsinogens are 
markers of different histologic conditions including gastritis and atrophy (142). 
Atrophy and inflammation are often mixed and both present in the same stomach. 
When inflammation burns out, atrophy detection would be more precise. Additionally 
gastritis could be of distinct etiologies in cancer patients. PGII has been suggested as a 
marker for all types of gastritis (143, 144). We observed an association between 
serologic non-atrophic pangastritis (measured by PGII) with ESCC risk. This finding 
raised the possibility of developing gastritis secondary to esophageal cancer. This could 
be happened as; 
 
- Cancer patients may develop gastritis due to non-steroidal anti-
inflammatory drug (NSAIDs) use, opportunistic infections in the stomach 
(Cytomegalovirus, Epstein-Barr virus), and malnutrition (145).  
- Stage of tumors in most of our study population were III or IV at the time 
of diagnosis and dysphagia was the presenting symptom which might led to 
high proportion of NSAID consumption among cases compared to controls.  
 
The best we could conclude was that in studying the serologic relationship between 
gastric atrophy and ESCC when serum collection period is close to cancer diagnosis, 
the association might be influenced by severe inflammation in stomach. This condition 
will elevate secretion of PGII and influences validity of PGI/PGII ratio for detection of 
atrophy. Which if happens, it decreases PGI/PGII ratio and might inflate the estimate of 
risk.   
Sever inflammation might influence the assessment of PGI accuracy as well. 
Histology is considered as the gold standard for gastric atrophy diagnosis, however 
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mucosal inflammation and separation of glands by inflammatory infiltrate would add 
more diagnostic difficulties in severe gastritis (119). The error probabilities for 
unexposed cases and controls might not be identical because inflammation among our 
cancer patients was more probable than healthy controls. To decrease the effect of 
mixed category, we stratified gastric fundal atrophy by the presence of non-atrophic 
pangastritis and observed an increased ESCC risk just in strata without severe 
inflammation. 
Furthermore H. pylori eradication and use of proton pump inhibitors are both affect 
pepsinogen level. Studies have shown PGI is a more stable marker after H. pylori 
eradication (146, 147). We did not collect specific information on treatment for H. 
pylori and used PGI alone as a marker of fundal atrophy. Similar ability of PGI/PGII 
ratio and PGI has been previously reported (148) but majority of the studies showed 
superior ability of the joined use of PGI and PGI/PGII ratio (149) or the PGI/PGII ratio 
alone (150-152). In our study sample, combining PGI and PGI/PGII ratio rendered a 
risk for association between fundal atrophy and ESCC risk without further stratifying 
by the presence of pangastritis. 
In terms of the magnitude of risk, the result based on our validated threshold 
(combination of PGI and PGI/PGII ratio) was not different from applying PGI alone 
with stratification by PGII level. Using both criteria we detected an approximately 2-
fold risk for ESCC. Prevalence of serologic atrophy in our study population was similar 
to the one in the low risk area for ESCC (10%).  
In this study, we could not detect any association between infection with CagA 
positive H. pylori and ESCC risk. Spontaneous disappearance of H. pylori over time or 
H. pylori eradication might influence our estimate. Immunodeficiency among advanced 
malnourished cancer patients could be another explanation as their immune response to 
antigens might be declined. These possibilities could lead to heterogeneity of our 
reference group as H. pylori negative category. It is plausible that in this aged 
population with high prevalence of CagA+ (approximately 90%) our serologic 
measurement of previous H. pylori infection is not conclusive. 
We found suggestive evidence that the estimated joint effect of  poor dental hygiene 
and gastric atrophy together was larger than the sum of their effects alone. This finding 
could be linked to the joint effect of bacterial overgrowth in both atrophic stomach and 
low hygiene periodontal mucosa (153). Upstream microbial community members from 
the oral mucosa have the potential to translocate to the stomach by salivary follow, and 
they might act as reservoirs for recolonization.  
The observed interaction might be due to other mechanisms: Poor orodental health 
may be an indicator of a less healthy life style. However we did not detect association 
between education as a socioeconomic status indicator and DMFT. Also low DMFT 
could be a marker for distinct diet due to reduced masticatory ability. Yet the detected 
association might be due to residual confounding. 
 
6.2.3 Gastric mucosa-associated microbiota and risk of esophageal 
squamous dysplasia and squamous cell carcinoma 
In this study, we observed a significant difference in microbiota composition of 
gastric fundal mucosa in subjects with early ESCC and squamous dysplasia compared 
to those with normal esophagus. This difference remained stable after exclusion of 
cancer cases. 
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Similar to other studies on gastric mucosal microbiota (71), the most common phyla 
in our samples were Proteobacteria, Firmicutes, Bacteroidetes, Actinobacteria, and 
Fusobacteria. 
The relation between H. pylori and ESCC risk is controversial. H. pylori abundance 
might be a single most important factor in diversity of gastric microbiota. In our study 
population, more than 80% were seropositive for H. pylori (121). A cluster of subjects 
with extremely low and zero Helicobacteraceae abundance showed low diversity. This 
group of subjects might be representative of: 
- Those with healthy stomach with acidic environment and without H. pylori 
infection.  
- Those who have been successfully treated upon H. pylori eradication program 
or H. pylori has been self-eradicated. 
This pattern influenced structure of sample clusters, with marginal difference in 
proportion of esophageal cancer/dysplasia subjects and control individuals in the 2 
clusters shaped by OTUs. 
In this study, 16S rRNA with coverage of 464 nt of region V3-V4 was used to 
distinguish bacteria. Although it did not cover whole hyper variable V1-V9 regions, the 
most divergent regions were covered and it was possible to align with SILVA reference 
with 90.5% coverage.  
Most of gut microbiota are anaerobes and difficult to cultivate and some of them 
could not be assigned to reference databases. Through OTU formation we tried to 
reduce this effect. Low number of study subjects in the pyrosequencing platform was 
compensated with higher depth of sequencing. Number of reads per sample in our 
study was around 3000. While studies have shown that a depth of 100 read is enough to 
separately cluster microbiota of healthy from inflamed bowel, to separate microbiota 
clusters of lean from obese 10,000 reads are needed (154). It is noteworthy that the 
possible difference in microbiota harboring in organs adjacent to cancerous tissue 
might be more subtle than the cancerous tissue.  Like any PCR-based methods, 
amplification bias is a concern as some less abundant taxa might be underestimated or 
ignored. 
   
6.2.4 Animal contact and risk of esophageal squamous cell carcinoma 
We found an increased risk of ESCC among those who were in contact with domestic 
animals, particularly with ruminants which showed a more than 8-fold increased risk of 
ESCC. 
Other observations verified our results on high level of contact between human and 
animals in study area. Golestan province has the highest incidence of animal bite and 
animal rabies compared to its neighbor provinces (155). Moreover serologic prevalence 
of human hydatidosis, a common zoonotic disease with canine-cattle-human cycle, is 
2.3% in the study area which is higher than its neighbor regions (156). Population of 
domesticated ruminants in the catchment area during the study period was 1,733,000 
with 83% small ruminants (74% sheep and 9% goat) and 17% cattle, which did not 
differ in total number from its neighbor areas with lower incidence rate of esophageal 
cancer (157). Even though the ruminant population in the study area is increasing, by 
improvement in the lifestyle of inhabitants (158) and industrialized animal husbandry, 
the contact with animals is decreasing in parallel with decline in ESCC incidence.  
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Contact with canine showed a two-fold increased risk for ESCC. This contact includes 
domestic and stray dogs. Wild canines are distributed in the study area in large extent 
and domestic dogs are applied by villagers to guard ruminants which could be one 
explanation for this association. After combining exposure to both ruminants and dogs, 
the risk due to only dogs disappeared and no excess risk was attributable to the contact 
with both animals compared to ruminants alone. 
An excess risk of esophageal cancer among poultry workers has been reported (93), 
although we did not find any association between poultry and ESCC in our study. 
Possible explanation could be that in the cohort of poultry related industry the type of 
esophageal cancer has not been stated: whether majority were adenocarcinoma or 
squamous cell carcinoma. Further lack of adjustment for major confounders i.e. 
tobacco smoking, alcohol consumption, and contact with other animals could be 
another concern. 
In the majority of subjects, the start of exposure to ruminants was from birth. Based 
on common lifestyle in the study area we can speculate that subjects were exposed to 
ruminants’ materials prenatally. Median duration of contact with ruminants was 54 
years which is approximately a lifelong exposure.  
One explanation for our finding could be exposure to ruminants’ products without 
industrial and healthy processing which is more common among villagers who keep 
animals within household. A study showed that small ruminants fed by a family of 
Euphorbiaceae flower plants extract a group of carcinogens (diterpene ester) in their 
milk (159). This genus is one of the most species-rich in flowering plants taxonomy 
and several of its species occur in the study area (160). We keep reservation that the 
association we observed in this study might be due to dietary factors in ruminants.  
Another possible explanation for our findings is animal zoonoses i.e. viruses which 
could cause cancer in ruminants. In addition to the multi-host nature of some zoonoses, 
the transmission pattern could be complex, i.e. rodents as carriers or wild animals as 
sources.  
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7 CONCLUSION    
 
 Opium and tobacco consumption are associated with ESCC risk. 
 
 Gastric fundal atrophy in the absence of severe gastritis is associated with the 
risk of ESCC. Poor dental health and oral hygiene habit may act synergistically 
in increasing the risk. 
 
 Applying high-throughput DNA sequencing, gastric microbiota composition 
differs between subjects with esophageal cancer or dysplasia and those with 
normal esophagus. Confirmation of this early result is needed. 
 
 Inhabitants of high risk area for esophageal cancer in northern Iran who were in 
long-term contact with ruminants have an about 8-fold risk for ESCC.   
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8 FUTURE STUDIES 
 
The underlying mechanism for the observed association between opium consumption 
and ESCC is not known. Recent studies have shown opium is linked to the risk of 
gastric adenocarcinoma in the same study area. Further studies are needed to explain 
the source of this association. 
 
Although serologic marker of gastric atrophy has been linked to ESCC, dose-
response relationship between severity of fundal atrophy and ESCC was once studied 
and failed to show any relation. One of the hypotheses for this association is the effect 
of atrophy on composition of gastric microbiota. This hypothesis is needed to be tested 
through next generation sequencing methods of gastric biopsies from atrophic and non-
atrophic stomach tissues. The possible synergism with poor orodental hygiene warrants 
larger sample size and adding microbiological examination of oral mucosa and saliva.  
 
The marginal difference in composition of gastric microbiota among those with 
normal and pre-neoplastic esophagus is needed to be repeated by other sequencing 
platform with higher sequencing depth. To verify the validity of phylogenetic 
candidates, qPCR of tissue samples with specific primers should be performed.  
 
The observed strong association between animal contact and ESCC remains to be 
explained. It might be due to a shared environment, infectious agent(s), or a chance 
finding. As the first step, evaluation of serum virome through next generation 
sequencing might help to evaluate possible zoonotic origin of the observed link.  
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